Ultragenyx Pharmaceutical Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 01/29/2026 | 10.26 M | $236.07 M | 1.29% | 10.41% |
| BLACKROCK, INC. | 02/12/2026 | 6.63 M | $152.53 M | 3.21% | 6.73% |
| STATE STREET CORP | 02/13/2026 | 4.30 M | $98.97 M | 16.54% | 4.36% |
| JPMORGAN CHASE & CO | 02/11/2026 | 3.97 M | $91.40 M | -0.93% | 3.98% |
| SANDS CAPITAL MANAGEMENT, LLC | 02/13/2026 | 3.49 M | $80.17 M | -7.54% | 3.49% |
| RTW INVESTMENTS, LP | 02/17/2026 | 3.00 M | $69.00 M | -7.92% | 3.04% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 2.77 M | $63.77 M | 0.00% | 2.81% |
| FMR LLC | 02/17/2026 | 2.67 M | $61.32 M | -63.39% | 2.70% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 2.46 M | $56.62 M | 26.57% | 2.50% |
| CITADEL ADVISORS LLC | 02/17/2026 | 2.33 M | $53.50 M | 602.86% | 2.36% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/17/2026 | 2.02 M | $46.44 M | 0.00% | 2.05% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 02/17/2026 | 1.97 M | $45.20 M | 83.81% | 1.99% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/13/2026 | 1.90 M | $43.69 M | 22.93% | 1.93% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.84 M | $42.29 M | 16.31% | 1.86% |
| MORGAN STANLEY | 02/13/2026 | 1.83 M | $42.00 M | 100.65% | 1.85% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/13/2026 | 1.75 M | $40.23 M | -19.30% | 1.77% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 1.55 M | $35.75 M | -32.72% | 1.58% |
| ABRDN PLC | 01/16/2026 | 1.47 M | $33.81 M | 50.97% | 1.47% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.36 M | $31.29 M | 82.33% | 1.38% |
| GW&K INVESTMENT MANAGEMENT, LLC | 02/11/2026 | 1.38 M | $31.63 M | 19.58% | 1.38% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 1.27 M | $29.15 M | 1.68% | 1.29% |
| NORGES BANK | 02/10/2026 | 1.26 M | $29.00 M | 100.00% | 1.26% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 1.23 M | $26.56 M | -15.56% | 1.23% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.21 M | $27.92 M | 85.33% | 1.23% |
| JANE STREET GROUP, LLC | 02/12/2026 | 1.02 M | $23.49 M | 188.42% | 1.04% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 903.05 K | $20.77 M | 57.60% | 0.92% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 880.64 K | $20.25 M | 787.63% | 0.89% |
| RUSSELL INVESTMENTS GROUP, LTD. | 02/17/2026 | 840.82 K | $19.34 M | 0.04% | 0.85% |
| NUVEEN, LLC | 02/12/2026 | 801.47 K | $18.43 M | 17.49% | 0.81% |
| CANDRIAM S.C.A. | 04/30/2026 | 799.38 K | $18.39 M | 5.92% | 0.81% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/17/2026 | 741.62 K | $17.06 M | -35.21% | 0.75% |
| UBS GROUP AG | 01/29/2026 | 668.81 K | $15.38 M | 22.26% | 0.68% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 643.36 K | $14.80 M | 33.32% | 0.65% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 631.30 K | $14.52 M | 104.70% | 0.64% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 599.47 K | $13.79 M | -61.23% | 0.60% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 598.92 K | $13.78 M | -0.21% | 0.60% |
| POLAR CAPITAL HOLDINGS PLC | 02/17/2026 | 556.63 K | $12.80 M | -4.64% | 0.56% |
| NORTHERN TRUST CORP | 02/17/2026 | 526.69 K | $12.11 M | 5.50% | 0.53% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 520.05 K | $11.96 M | 100.00% | 0.53% |
| HRT FINANCIAL LP | 02/12/2026 | 501.68 K | $11.54 M | 100.00% | 0.51% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 497.10 K | $11.43 M | 68.17% | 0.50% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 481.60 K | $11.08 M | -6.97% | 0.49% |
| JEFFERIES FINANCIAL GROUP INC. | 02/09/2026 | 477.09 K | $10.97 M | 100.00% | 0.48% |
| PALO ALTO INVESTORS LP | 02/17/2026 | 461.29 K | $10.61 M | 24.83% | 0.47% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 424.05 K | $9.75 M | 30.00% | 0.43% |
| FRED ALGER MANAGEMENT, LLC | 02/17/2026 | 411.86 K | $9.47 M | -8.21% | 0.42% |
| LEGAL & GENERAL GROUP PLC | 02/09/2026 | 411.27 K | $9.46 M | 2.10% | 0.41% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 404.70 K | $9.31 M | 170.16% | 0.41% |
| MOORE CAPITAL MANAGEMENT, LP | 02/17/2026 | 403.30 K | $9.28 M | 100.00% | 0.41% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 400.36 K | $9.21 M | -16.06% | 0.41% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ultragenyx Pharmaceutical Inc. institutional Ownership - FAQ's
During the previous two years, 446 institutional investors and hedge funds held shares of Ultragenyx Pharmaceutical Inc.. The most heavily invested institutionals were:
Assenagon Asset Management S.A.: 2.26 M
Candriam S.C.A.: 1.1 M
UBS Group AG: 832,740
Nuveen, LLC: 662,054
Pictet Asset Management Holding SA: 603,571
Privium Fund Management B.V.: 364,802
95.28% of Ultragenyx Pharmaceutical Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 109.47 M shares in the last 24 months. This purchase volume represents approximately $2.48 B in transactions.